Lucida Medical

Macmillan Ventures, the recently launched venture capital arm of Macmillan Cancer Support, has participated in an £8.7 million funding round for Lucida Medical, a Cambridge-based health tech startup focused on medical innovations in cancer care.

Summary of transaction details:

• Value: £8.7 million
• Sector: Healthcare & Biotech
• Advisor: Not specified
• Key Entities: Lucida Medical (Target), Macmillan Ventures (Investor)
• Location: Cambridge (Target's base)

Note: This investment underscores Macmillan Ventures' strategic initiative to deploy philanthropic capital into innovative health technology solutions, aiming to significantly advance cancer treatment and support services.